Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

How can we minimise the use of regular oral corticosteroids in asthma?

Bourdin A, Adcock I, Berger P, Bonniaud P, Chanson P, Chenivesse C, de Blic J, Deschildre A, Devillier P, Devouassoux G, Didier A, Garcia G, Magnan A, Martinat Y, Perez T, Roche N, Taillé C, Val P, Chanez P.

Eur Respir Rev. 2020 Feb 5;29(155). pii: 190085. doi: 10.1183/16000617.0085-2019. Print 2020 Mar 31. Review. Erratum in: Eur Respir Rev. 2020 Feb 12;29(155):.

2.

Matching-Adjusted Comparison of Oral Corticosteroid Reduction in Asthma: Systematic Review of Biologics.

Bourdin A, Husereau D, Molinari N, Golam S, Siddiqui MK, Lindner L, Xu X.

Clin Exp Allergy. 2020 Jan 13. doi: 10.1111/cea.13561. [Epub ahead of print]

PMID:
31943429
3.

Integrating high dose inhaled corticosteroids into oral corticosteroids stewardship.

Bourdin A, Suehs C, Charriot J.

Eur Respir J. 2020 Jan 2;55(1). pii: 1902193. doi: 10.1183/13993003.02193-2019. Print 2020 Jan. No abstract available.

PMID:
31896681
4.

Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma.

Bourdin A, Shaw D, Menzies-Gow A, FitzGerald JM, Bleecker ER, Busse WW, Ferguson GT, Brooks L, Barker P, Gil EG, Martin UJ.

J Asthma. 2019 Dec 26:1-9. doi: 10.1080/02770903.2019.1705333. [Epub ahead of print]

PMID:
31859541
5.

Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma.

FitzGerald JM, Bleecker ER, Bourdin A, Busse WW, Ferguson GT, Brooks L, Barker P, Martin UJ.

J Asthma Allergy. 2019 Dec 9;12:401-413. doi: 10.2147/JAA.S227170. eCollection 2019.

6.

Reply to: Altered Calcium in Ciliary Dysfunction: Potential Role of ER Stress and Ciliophagy.

Petit A, Knabe L, Khelloufi K, Jory M, Gras D, Cabon Y, Begg M, Richard S, Massiera G, Chanez P, Vachier I, Bourdin A.

Am J Respir Cell Mol Biol. 2019 Dec;61(6):795-796. doi: 10.1165/rcmb.2019-0263LE. No abstract available.

PMID:
31774332
7.

"Rehab for all!" Is it too early in pulmonary arterial hypertension?

Bertoletti L, Bouvaist H, Tromeur C, Bezzeghoud S, Dauphin C, Enache I, Bourdin A, Seronde MF, Montani D, Turquier S, Pison C; FONCE-HTAP investigators; Steering committee.

Eur Respir J. 2019 Nov 7;54(5). pii: 1901558. doi: 10.1183/13993003.01558-2019. Print 2019 Nov. No abstract available.

PMID:
31699779
8.

What is the remaining status of adaptive servo-ventilation? The results of a real-life multicenter study (OTRLASV-study) : Adaptive servo-ventilation in real-life conditions.

Jaffuel D, Philippe C, Rabec C, Mallet JP, Georges M, Redolfi S, Palot A, Suehs CM, Nogue E, Molinari N, Bourdin A.

Respir Res. 2019 Oct 29;20(1):235. doi: 10.1186/s12931-019-1221-9.

9.

Reply to Wand et al.: Role of Transbronchial Cryobiopsy in Interstitial Lung Diseases: An Ongoing Tale.

Bourdin A, Suehs CM, Colby TV, Vachier I, Molinari N, Romagnoli M.

Am J Respir Crit Care Med. 2020 Jan 15;201(2):260-261. doi: 10.1164/rccm.201909-1736LE. No abstract available.

10.

Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management.

Bleecker ER, Menzies-Gow AN, Price DB, Bourdin A, Sweet S, Martin AL, Alacqua M, Tran TN.

Am J Respir Crit Care Med. 2020 Feb 1;201(3):276-293. doi: 10.1164/rccm.201904-0903SO.

11.

Is the 2013 American Thoracic Society CPAP-tracking system algorithm useful for managing non-adherence in long-term CPAP-treated patients?

Rotty MC, Mallet JP, Suehs CM, Martinez C, Borel JC, Rabec C, Bourdin A, Molinari N, Jaffuel D.

Respir Res. 2019 Sep 12;20(1):209. doi: 10.1186/s12931-019-1150-7.

12.

ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions.

Bourdin A, Bjermer L, Brightling C, Brusselle GG, Chanez P, Chung KF, Custovic A, Diamant Z, Diver S, Djukanovic R, Hamerlijnck D, Horváth I, Johnston SL, Kanniess F, Papadopoulos N, Papi A, Russell RJ, Ryan D, Samitas K, Tonia T, Zervas E, Gaga M.

Eur Respir J. 2019 Sep 28;54(3). pii: 1900900. doi: 10.1183/13993003.00900-2019. Print 2019 Sep.

PMID:
31467120
13.

Cryobiopsy Compared with Surgical Lung Biopsy in ILD: Reply to Maldonado et al., Froidure et al., Bendstrup et al., Agarwal et al., Richeldi et al., Rajchgot et al., and Quadrelli et al.

Romagnoli M, Colby TV, Suehs CM, Vachier I, Molinari N, Bourdin A.

Am J Respir Crit Care Med. 2019 Oct 1;200(7):944-946. doi: 10.1164/rccm.201906-1252LE. No abstract available.

14.

COPD beyond proximal bronchial obstruction: phenotyping and related tools at the bedside.

Capron T, Bourdin A, Perez T, Chanez P.

Eur Respir Rev. 2019 Jul 8;28(152). pii: 190010. doi: 10.1183/16000617.0010-2019. Print 2019 Jun 30. Review.

15.

A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Relative to Umeclidinium/Vilanterol Dry Powder Inhaler in COPD.

Maltais F, Ferguson GT, Feldman GJ, Deslee G, Bourdin A, Fjällbrant H, Siwek-Posłuszna A, Jenkins MA, Martin UJ.

Adv Ther. 2019 Sep;36(9):2434-2449. doi: 10.1007/s12325-019-01015-3. Epub 2019 Jul 2.

PMID:
31267366
16.

Promoting transitions of care, safety, and medication adherence for patients taking fingolimod in community pharmacies.

Bourdin A, Schluep M, Bugnon O, Berger J.

Am J Health Syst Pharm. 2019 Jul 18;76(15):1150-1157. doi: 10.1093/ajhp/zxz106.

PMID:
31201774
17.

Heat-moulded versus custom-made mandibular advancement devices for obstructive sleep apnoea: a randomised non-inferiority trial.

Pépin JL, Raymond N, Lacaze O, Aisenberg N, Forcioli J, Bonte E, Bourdin A, Launois S, Tamisier R, Molinari N.

Thorax. 2019 Jul;74(7):667-674. doi: 10.1136/thoraxjnl-2018-212726. Epub 2019 May 3.

PMID:
31053619
18.

CCSP counterbalances airway epithelial-driven neutrophilic chemotaxis.

Knabe L, Petit A, Vernisse C, Charriot J, Pugnière M, Henriquet C, Sasorith S, Molinari N, Chanez P, Berthet JP, Suehs C, Vachier I, Ahmed E, Bourdin A.

Eur Respir J. 2019 Jul 11;54(1). pii: 1802408. doi: 10.1183/13993003.02408-2018. Print 2019 Jul.

PMID:
31023848
19.

Detection of Mycobacterium tuberculosis in paucibacillary sputum: performances of the Xpert MTB/RIF ultra compared to the Xpert MTB/RIF, and IS6110 PCR.

Kolia-Diafouka P, Carrère-Kremer S, Lounnas M, Bourdin A, Kremer L, Van de Perre P, Godreuil S, Tuaillon E.

Diagn Microbiol Infect Dis. 2019 Aug;94(4):365-370. doi: 10.1016/j.diagmicrobio.2019.02.008. Epub 2019 Feb 21.

PMID:
31005403
20.

Bronchial Epithelial Calcium Metabolism Impairment in Smokers and Chronic Obstructive Pulmonary Disease. Decreased ORAI3 Signaling.

Petit A, Knabe L, Khelloufi K, Jory M, Gras D, Cabon Y, Begg M, Richard S, Massiera G, Chanez P, Vachier I, Bourdin A.

Am J Respir Cell Mol Biol. 2019 Oct;61(4):501-511. doi: 10.1165/rcmb.2018-0228OC.

PMID:
30943377
21.

Adverse publicity of serious side effects to healthy volunteers has limited effect on willingness-to-participate in clinical trials.

Molinari N, Suehs C, Vachier I, Pahus L, Halimi L, Gamez AS, Chanez P, Bourdin A.

Clin Trials. 2019 Aug;16(4):440-442. doi: 10.1177/1740774519840268. Epub 2019 Mar 29. No abstract available.

PMID:
30922104
22.

Poor Concordance between Sequential Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy in the Diagnosis of Diffuse Interstitial Lung Diseases.

Romagnoli M, Colby TV, Berthet JP, Gamez AS, Mallet JP, Serre I, Cancellieri A, Cavazza A, Solovei L, Dell'Amore A, Dolci G, Guerrieri A, Reynaud P, Bommart S, Zompatori M, Dalpiaz G, Nava S, Trisolini R, Suehs CM, Vachier I, Molinari N, Bourdin A.

Am J Respir Crit Care Med. 2019 May 15;199(10):1249-1256. doi: 10.1164/rccm.201810-1947OC.

PMID:
30864813
23.

Randomised controlled trials in severe asthma: selection by phenotype or stereotype.

Pahus L, Jaffuel D, Vachier I, Bourdin A, Suehs CM, Molinari N, Chanez P.

Eur Respir J. 2019 Feb 7;53(2). pii: 1802187. doi: 10.1183/13993003.02187-2018. Print 2019 Feb. No abstract available.

PMID:
30759420
24.

Goblet cell hyperplasia as a feature of neutrophilic asthma.

Alagha K, Bourdin A, Vernisse C, Garulli C, Tummino C, Charriot J, Vachier I, Suehs C, Chanez P, Gras D.

Clin Exp Allergy. 2019 Jun;49(6):781-788. doi: 10.1111/cea.13359. Epub 2019 Feb 27.

PMID:
30710420
25.

Severe asthma treated by bronchial thermoplasty: A success not due to the small airways?

Chanez P, Pahus L, Charriot J, Bourdin A.

Respirology. 2019 May;24(5):402-403. doi: 10.1111/resp.13481. Epub 2019 Jan 29. No abstract available.

PMID:
30694006
26.

The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database.

Bourdin A, Fabry-Vendrand C, Ostinelli J, Ait-Yahia M, Darnal E, Bouee S, Laurendeau C, Bureau I, Gourmelen J, Chouaid C.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1477-1487. doi: 10.1016/j.jaip.2018.12.029. Epub 2019 Jan 25.

PMID:
30685573
27.

Indirect treatment comparison of asthma biologics fraught with methodology issues.

Bourdin A, Molinari N.

J Allergy Clin Immunol. 2019 Mar;143(3):1266-1267. doi: 10.1016/j.jaci.2018.11.024. Epub 2019 Jan 11. No abstract available.

PMID:
30639069
28.

Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases.

Eyries M, Montani D, Nadaud S, Girerd B, Levy M, Bourdin A, Trésorier R, Chaouat A, Cottin V, Sanfiorenzo C, Prevot G, Reynaud-Gaubert M, Dromer C, Houeijeh A, Nguyen K, Coulet F, Bonnet D, Humbert M, Soubrier F.

Eur Respir J. 2019 Mar 14;53(3). pii: 1801371. doi: 10.1183/13993003.01371-2018. Print 2019 Mar.

PMID:
30578383
29.

Improving patient access to hepatitis C antiviral medicines in Switzerland: Understanding the financial risks for community pharmacies.

Berger J, Bourdin A, Pires F, Backes C, Perraudin C, Bugnon O.

J Eval Clin Pract. 2019 Jun;25(3):476-481. doi: 10.1111/jep.13081. Epub 2018 Dec 21.

PMID:
30575217
30.

KIT as a therapeutic target for non-oncological diseases.

Martinez-Anton A, Gras D, Bourdin A, Dubreuil P, Chanez P.

Pharmacol Ther. 2019 May;197:11-37. doi: 10.1016/j.pharmthera.2018.12.008. Epub 2018 Dec 14. Review.

31.

Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency.

Perotin JM, Leroy S, Marquette CH, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Barbe C, Deslee G; REVOLENS Study Group.

Int J Chron Obstruct Pulmon Dis. 2018 Nov 5;13:3645-3649. doi: 10.2147/COPD.S176366. eCollection 2018.

32.

Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma.

Khatri S, Moore W, Gibson PG, Leigh R, Bourdin A, Maspero J, Barros M, Buhl R, Howarth P, Albers FC, Bradford ES, Gilson M, Price RG, Yancey SW, Ortega H.

J Allergy Clin Immunol. 2019 May;143(5):1742-1751.e7. doi: 10.1016/j.jaci.2018.09.033. Epub 2018 Oct 23.

33.

Systematic Screening Using Luminex for De Novo C3d Fixing of Class II Donor-Specific Antibodies Is Correlated With Luminex Mean Fluorescence Intensity in Renal Transplant Patients.

Villemaire M, Jouve T, Bourdin A, Janbon B, Pinel N, Tetaz R, Terrier N, Rostaing L, Masson D, Malvezzi P.

Exp Clin Transplant. 2019 Aug;17(4):483-489. doi: 10.6002/ect.2018.0063. Epub 2018 Oct 19.

34.

Optimized Lysis-Extraction Method Combined With IS6110-Amplification for Detection of Mycobacterium tuberculosis in Paucibacillary Sputum Specimens.

Kolia-Diafouka P, Godreuil S, Bourdin A, Carrère-Kremer S, Kremer L, Van de Perre P, Tuaillon E.

Front Microbiol. 2018 Sep 25;9:2224. doi: 10.3389/fmicb.2018.02224. eCollection 2018.

35.

Matching-adjusted indirect comparison of benralizumab versus interleukin-5 inhibitors for the treatment of severe asthma: a systematic review.

Bourdin A, Husereau D, Molinari N, Golam S, Siddiqui MK, Lindner L, Xu X.

Eur Respir J. 2018 Nov 29;52(5). pii: 1801393. doi: 10.1183/13993003.01393-2018. Print 2018 Nov.

36.

Generation of the induced pluripotent stem cell line UHOMi001-A from a patient with mutations in CCDC40 gene causing Primary Ciliary Dyskinesia (PCD).

Ahmed E, Sansac C, Fieldes M, Bergougnoux A, Bourguignon C, Mianné J, Arnould C, Vachier I, Assou S, Bourdin A, De Vos J.

Stem Cell Res. 2018 Dec;33:15-19. doi: 10.1016/j.scr.2018.09.019. Epub 2018 Sep 28.

37.

Induced Pluripotent Stem Cells for Primary Ciliary Dyskinesia Modeling and Personalized Medicine.

Mianné J, Ahmed E, Bourguignon C, Fieldes M, Vachier I, Bourdin A, Assou S, De Vos J.

Am J Respir Cell Mol Biol. 2018 Dec;59(6):672-683. doi: 10.1165/rcmb.2018-0213TR. Review.

38.

Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study).

Bulsei J, Leroy S, Perotin JM, Mal H, Marquette CH, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Salaün M, Marceau A, Dukic S, Barbe C, Bonnaire M, Deslee G, Durand-Zaleski I; REVOLENS study group.

Respir Res. 2018 May 9;19(1):84. doi: 10.1186/s12931-018-0796-x.

39.

B cells response directed against Cut4 and CFP21 lipolytic enzymes in active and latent tuberculosis infections.

Rénier W, Bourdin A, Rubbo PA, Peries M, Dedieu L, Bendriss S, Kremer L, Canaan S, Terru D, Godreuil S, Nagot N, Van de Perre P, Tuaillon E.

PLoS One. 2018 Apr 30;13(4):e0196470. doi: 10.1371/journal.pone.0196470. eCollection 2018.

40.

Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension Registry.

Montani D, Henry J, O'Connell C, Jaïs X, Cottin V, Launay D, Habib G, Bourdin A, Jevnikar M, Savale L, Rottat L, Simonneau G, Sitbon O, Humbert M, Allanore Y.

Respiration. 2018;95(4):244-250. doi: 10.1159/000485631. Epub 2018 Feb 28.

41.

Impact of sacubitril-valsartan combination in patients with chronic heart failure and sleep apnoea syndrome: the ENTRESTO-SAS study design.

Jaffuel D, Molinari N, Berdague P, Pathak A, Galinier M, Dupuis M, Ricci JE, Mallet JP, Bourdin A, Roubille F.

ESC Heart Fail. 2018 Jun;5(3):222-230. doi: 10.1002/ehf2.12270. Epub 2018 Feb 22.

42.

Asthma, COPD, and overlap in a national cohort: ACO on a gradient.

Bourdin A, Suehs CM, Marin G, Vachier I, Matzner-Lober E, Chanez P, Molinari N; COBRA Consortium.

J Allergy Clin Immunol. 2018 Apr;141(4):1516-1518. doi: 10.1016/j.jaci.2017.11.049. Epub 2018 Jan 31. No abstract available.

PMID:
29355677
43.

Impact of psychological factors on the health-related quality of life of patients treated for pulmonary arterial hypertension.

Halimi L, Marin G, Molinari N, Gamez AS, Boissin C, Suehs CM, Vachier I, Bourdin A.

J Psychosom Res. 2018 Feb;105:45-51. doi: 10.1016/j.jpsychores.2017.12.003. Epub 2017 Dec 6.

44.

RV function improvement following nitric oxide inhalation demonstrated by gated blood pool SPECT in a patient with primary pulmonary hypertension.

Ben Bouallègue F, Vauchot F, Bourdon A, Benkiran M, Boissin C, Charriot J, Bourdin A, Mariano-Goulart D.

J Nucl Cardiol. 2018 Dec;25(6):2174-2176. doi: 10.1007/s12350-017-1171-x. Epub 2018 Jan 10. No abstract available.

45.

Two-year follow-up after endobronchial coil treatment in emphysema: results from the REVOLENS study.

Deslée G, Leroy S, Perotin JM, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Salaün M, Marceau A, Dury S, Benzaquen J, Bonnaire M, Dukic S, Barbe C, Marquette CH; , on behalf of the REVOLENS Study Group13; REVOLENS Study Group.

Eur Respir J. 2017 Dec 21;50(6). pii: 1701740. doi: 10.1183/13993003.01740-2017. Print 2017 Dec. No abstract available.

46.

Mortality: a neglected outcome in OCS-treated severe asthma.

Bourdin A, Molinari N, Vachier I, Pahus L, Suehs C, Chanez P.

Eur Respir J. 2017 Nov 30;50(5). pii: 1701486. doi: 10.1183/13993003.01486-2017. Print 2017 Nov. No abstract available.

47.

The feasibility of a mandibular movement test as a screening tool for polysomnography candidates.

Rotty MC, Mallet JP, Borel JC, Suehs CM, Bourdin A, Molinari N, Jaffuel D.

Eur Respir J. 2017 Nov 30;50(5). pii: 1701076. doi: 10.1183/13993003.01076-2017. Print 2017 Nov. No abstract available.

48.

Lung development, regeneration and plasticity: From disease physiopathology to drug design using induced pluripotent stem cells.

Ahmed E, Sansac C, Assou S, Gras D, Petit A, Vachier I, Chanez P, De Vos J, Bourdin A.

Pharmacol Ther. 2018 Mar;183:58-77. doi: 10.1016/j.pharmthera.2017.10.002. Epub 2017 Oct 4. Review.

49.

Healthcare pathway and patients' expectations in pulmonary fibrosis.

Cottin V, Bourdin A, Crestani B, Prévot G, Guérin M, Bouquillon B.

ERJ Open Res. 2017 Apr 12;3(2). pii: 00134-2016. doi: 10.1183/23120541.00134-2016. eCollection 2017 Apr.

50.

Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.

Cadelis G, Ducrot R, Bourdin A, Rastogi N.

PLoS Negl Trop Dis. 2017 Aug 7;11(8):e0005841. doi: 10.1371/journal.pntd.0005841. eCollection 2017 Aug.

Supplemental Content

Loading ...
Support Center